INOVA FAIR OAKS HOSPITAL — History
CCN 490101 | 3-year financial timeline | COVID resilience: 86/100
🛡️ Public data only — no PHI permitted on this instance.
$382M
Latest Revenue (FY2022)
+12.0%
Revenue CAGR (3yr)
28.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $305M | $346M | $382M | +10.5% | +12.0% |
| Operating Expenses | $274M | $304M | $273M | -10.0% | -0.2% |
| Operating Margin | 10.0% | 12.3% | 28.5% | +132.6% | +68.8% |
| Net Income | $31M | $42M | $109M | +157.0% | +89.1% |
| Licensed Beds | 165 | 165 | 174 | +5.5% | +2.7% |
| Total Patient Days | 41,923 | 45,856 | 47,210 | +3.0% | +6.1% |
| Medicare Day % | 28% | 25% | 25% | +1.4% | -5.7% |
| Medicaid Day % | 8% | 6% | 7% | +10.6% | -4.6% |
COVID Impact & Recovery
Resilience Score: 86/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +25.4% ($305M → $382M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.0%
This Hospital
+7.6%
State Avg
Latest Margin
28.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $421M | 37.8% |
| FY2024 (proj) | $460M | 47.0% |
| FY2025 (proj) | $499M | 56.3% |